EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $224,750 | -18.3% | 31,000 | 0.0% | 0.04% | -22.2% |
| Q4 2022 | $274,970 | +116.5% | 31,000 | +198.1% | 0.04% | +104.5% |
| Q3 2022 | $127,000 | +3.3% | 10,400 | 0.0% | 0.02% | +4.8% |
| Q2 2022 | $123,000 | -37.9% | 10,400 | 0.0% | 0.02% | -44.7% |
| Q1 2022 | $198,000 | -28.3% | 10,400 | 0.0% | 0.04% | -37.7% |
| Q4 2021 | $276,000 | -63.9% | 10,400 | -44.1% | 0.06% | -63.7% |
| Q3 2021 | $764,000 | -56.5% | 18,600 | -40.0% | 0.17% | -53.8% |
| Q2 2021 | $1,756,000 | +190.2% | 31,000 | +115.3% | 0.36% | +191.2% |
| Q1 2021 | $605,000 | -71.9% | 14,400 | -53.2% | 0.12% | -77.9% |
| Q4 2020 | $2,156,000 | +0.4% | 30,750 | -59.8% | 0.56% | -0.5% |
| Q3 2020 | $2,147,000 | -28.8% | 76,500 | -25.0% | 0.57% | -26.1% |
| Q2 2020 | $3,017,000 | +48.4% | 102,000 | -0.5% | 0.77% | +40.3% |
| Q1 2020 | $2,033,000 | +3.3% | 102,500 | +54.1% | 0.55% | -12.6% |
| Q4 2019 | $1,969,000 | – | 66,500 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |